drugset / Trial / NCT02986880

Effect of Type-A Botulinum Toxin in the Post-radiosurgical Neck Contractures

NCT02986880 ↗

Phase 2 Completed 14 enrolled Hopital Foch
RandomizedParallel-groupTriple-blindTreatment

Summary

The main objective of the study is to estimate the efficiency and to determine the optimal dose of Botulinum toxin A, administered by intramuscular way in cervical spasms after radiotherapy, as well as the optimal sites for these injections. The concerned muscular groups are the sternocleidomastoid (SCM), the trapezius muscle and the splenius capitis.

Timeline

Start
2011-06
Primary completion
2014-01-10
Completion
2014-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 30 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 60 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Intramuscular

Indications